How to use macrophages to realise the treatment of tumour. (25th November 2020)

• Record Type: Journal Article
• Authors: Zhang, Xiaoyu; Li, Weinan; Sun, Jialin; Yang, Zhixin; Guan, Qingxia; Wang, Rui; Li, Xiuyan; Li, Yongji; Feng, Yufei; Wang, Yanhong
• Is Part Of: Journal of drug targeting. Volume 28:Number 10(2020)
• Page Start: 1034
• Page End: 1045
• Publication Date: 2020-11-25
• Subjects: Macrophages -- macrophages membrane -- tumour therapy -- targeting strategy -- drug delivery system; Drug delivery systems -- Periodicals; Drug Delivery Systems; Vehicles; Drug Administration Routes; Drug Evaluation; 615.7
• DOI: 10.1080/1061186X.2020.1775236
• Languages: English
• ISSNs: 1061-186X

Abstract

Abstract: Macrophages (Mø) are immune cells with natural phagocytic ability and play an important role in tumorigenesis, development and metastasis. Mø play a dual role of tumour inhibition and tumour promotion in tumour development due to their two different phenotypes. Mø in the tumour microenvironment have long been referred to as tumour-associated Mø (TAMs). Mø are mainly involved in tumour resistance, cancer metastasis and mediating immunosuppression. Nowadays, Mø and Mø membranes have been widely used in drug delivery systems (DDSs) because of their good biocompatibility, natural phagocytosis and their important role in tumour development. In this review, from the perspective of Mø's role in tumour development, we present strategies and drugs of Mø targeting and focusing on the several types of biomimetic nanoparticles constructed by Mø and Mø membranes in tumour therapy, and discuss the problem of this delivery system in present research and future directions.